The state's strategic drug reserves are in good condition, the head of the Food and Drug Organization: stocks of raw materials, manufactured drugs and stocks of drugs in the production and distribution chain under favorable conditions. The country has good resilience to provide long-term medicines. Locally produced insulin is available in sufficient quantity and abundance in the country. Due to problems with import routes and currency allocation in the commercial market rate for imported insulins, the price increase of these products is certain. Patients using Iranian insulin will not face any particular problem in terms of cost.